What is atypical is the fact that generic imatinib's list price has remained stubbornly high. In late 2017, almost two years after its patent expiration a month’s supply of branded Gleevec was ...

Imatinib (Gleevec, Novartis, Basel, Switzerland), formerly referred to as STI571, is an inhibitor of specific protein tyrosine kinases that was targeted to the platelet-derived growth factor (PDGF ...

In this Viewpoint, the authors discuss how imatinib could provide a potent therapeutic option for a variety of autoimmune and inflammatory diseases, for which current therapies are insufficient.

Imatinib, a selective inhibitor of the BCR-ABL tyrosine kinase, produces high response rates in patients with chronic-phase chronic myeloid leukemia (CML) who have had no response to interferon alf ...

Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference.

Imatinib has now been used by more than 100,000 patients worldwide, totaling more than 200,000 patient-years of exposure, she noted. Also, the CML patient population tends to be elderly, ...

By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT Third Quarter 2021 Financial and Operational Review Tenax Therapeutics, Inc. (NASDAQ:TENX) reported third quarter 2021 ...

Imatinib interruption should not be considered for patients with advanced gastrointestinal stromal tumor who do not have progressive disease, according to results of a randomized phase 3 trial ...

The Food and Drug Administration (FDA) has approved Imkeldi, an oral solution formulation of imatinib. Imkeldi is indicated to treat chronic myeloid leukemia, acute lymphoblastic leukemia ...

The FDA first approved imatinib (Gleevec, Novartis), a protein-tyrosine kinase inhibitor, in 2001 under the accelerated approval program for use in adult patients with chronic myelogenous leukemia ...

The generic form of the blockbuster cancer drug is being shipped to pharmacies. The generic is likely to cost 30 percent less than the brand-name version, but Gleevec's price doubled in recent years.